Clinical Trial Update: Feasibility of Using Bortezomib With or Without Chemotherapy in Patients With Atypical Teratoid/Rhabdoid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the feasibility of adding bortezomib, with or without standard chemotherapy, in patients with atypical teratoid/rhabdoid tumors …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Central Nervous System Tumors

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Taipei Medical University | Conditions: Atypical Teratoid/Rhabdoid Tumors (AT/RTs), Central Nervous System (CNS) Tumors | Phase 2 | Status: ACTIVE_NOT_RECRUITING